Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Heart Care Center
mi
from
East Syracuse, NY
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Heart Care Center
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
The Gables Natural Medicines Center & Day Spa Family Health Services
mi
from
Mayville, NY
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
The Gables Natural Medicines Center & Day Spa Family Health Services
mi
from
Mayville, NY
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
NYU School of Medicine
mi
from
New York, NY
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Rhinebeck Health Center
mi
from
Rhinebeck, NY
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Rhinebeck Health Center
mi
from
Rhinebeck, NY
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Staten Island Heart
mi
from
Staten Island, NY
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Staten Island Heart
mi
from
Staten Island, NY
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Schachter Center for Complementary Medicine
mi
from
Suffern, NY
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Schachter Center for Complementary Medicine
mi
from
Suffern, NY
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Integrative Medical Associates, PLLC
mi
from
Tryon, NC
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Integrative Medical Associates, PLLC
mi
from
Tryon, NC
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Celebration of Health Center
mi
from
Bluffton, OH
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Celebration of Health Center
mi
from
Bluffton, OH
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Ohio State University Medical Center
mi
from
Columbus, OH
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Comprehensive Heart Care, Inc.
mi
from
Toledo, OH
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Comprehensive Heart Care, Inc.
mi
from
Toledo, OH
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Upper Valley Family Care
mi
from
Troy, OH
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Upper Valley Family Care
mi
from
Troy, OH
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
COR Research
mi
from
Oklahoma City, OK
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
COR Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
St. Charles Health System
mi
from
Bend, OR
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
St. Charles Health System
mi
from
Bend, OR
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Center for Environmental Medicine
mi
from
Portland, OR
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Center for Environmental Medicine
mi
from
Portland, OR
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Wholistic Health Center
mi
from
Greensburg, PA
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Wholistic Health Center
mi
from
Greensburg, PA
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Woodlands Healing Research Center
mi
from
Quakertown, PA
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Woodlands Healing Research Center
mi
from
Quakertown, PA
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Lankenau Heart Institute
mi
from
Wynnewood, PA
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Lankenau Heart Institute
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Biogenesis Medical Center
mi
from
Landrum, SC
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Biogenesis Medical Center
mi
from
Landrum, SC
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Athens Surgery Clinic
mi
from
Athens, TN
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Athens Surgery Clinic
mi
from
Athens, TN
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
The Castle Clinic, PLLC
mi
from
Johnson City, TN
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
The Castle Clinic, PLLC
mi
from
Johnson City, TN
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Chelation Centers of Texas
mi
from
Texas City, TX
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Chelation Centers of Texas
mi
from
Texas City, TX
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Freedom Center for Advanced Medicine
mi
from
Provo, UT
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Freedom Center for Advanced Medicine
mi
from
Provo, UT
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
The Cardiovascular Group
mi
from
Fairfax, VA
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
The Cardiovascular Group
mi
from
Fairfax, VA
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Virginia Beach General Hospital
mi
from
Virginia Beach, VA
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Virginia Beach General Hospital
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Hope Medical Holistic Clinic
mi
from
Vancouver, WA
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Hope Medical Holistic Clinic
mi
from
Vancouver, WA
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
CaRE Foundation, Inc
mi
from
Wausau, WI
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
CaRE Foundation, Inc
mi
from
Wausau, WI
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Waters Preventive Medical Center, LTD
mi
from
Wisconsin Dells, WI
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Waters Preventive Medical Center, LTD
mi
from
Wisconsin Dells, WI
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated:  8/30/2013
Cline Medical Centre
mi
from
Nanaimo,
Trial to Assess Chelation Therapy (TACT)
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Cline Medical Centre
mi
from
Nanaimo,
Click here to add this to my saved trials
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal (TRUTH Study)
Status: Enrolling
Updated:  9/9/2013
NYU School of Medicine
mi
from
New York, NY
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal (TRUTH Study)
Status: Enrolling
Updated: 9/9/2013
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Tatum Ridge Internal Medicine
mi
from
Phoenix, AZ
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Tatum Ridge Internal Medicine
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Apex Research Institute
mi
from
Santa Ana, CA
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Apex Research Institute
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Tampa Bay Medical Research Inc.
mi
from
Clearwater, FL
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Tampa Bay Medical Research Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
DMI Research, Inc
mi
from
Pinellas Park, FL
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
DMI Research, Inc
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Maine Research Associates
mi
from
Auburn, ME
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Maine Research Associates
mi
from
Auburn, ME
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Henry Ford Hospital
mi
from
Detroit, MI
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
National Clinical Research - Norfolk, Inc.
mi
from
Norfolk, VA
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
National Clinical Research - Norfolk, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Stanford Hospital and Clinics
mi
from
Stanford, CA
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Denver Health Medical Center
mi
from
Denver, CO
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated:  9/16/2013
Baylor College of Medicine
mi
from
Houston, TX
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  9/16/2013
Cardio-Thoracic Surgeons, P.C.
mi
from
Birmingham, AL
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 9/16/2013
Cardio-Thoracic Surgeons, P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  9/16/2013
Cardiology PC
mi
from
Birmingham, AL
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 9/16/2013
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  9/16/2013
Heart Center Research, Llc
mi
from
Huntsville, AL
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 9/16/2013
Heart Center Research, Llc
mi
from
Huntsville, AL
Click here to add this to my saved trials
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  9/16/2013
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 9/16/2013
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  9/16/2013
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 9/16/2013
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  9/16/2013
Stanford University Medical Center
mi
from
Palo Alto, CA
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 9/16/2013
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials